Argos inhibits epidermal growth factor receptor signalling by ligand sequestration

The epidermal growth factor receptor (EGFR) has critical functions in development and in many human cancers. During development, the spatial extent of EGFR signalling is regulated by feedback loops comprising both well-understood activators and less well-characterized inhibitors. In Drosophila melanogaster the secreted protein Argos functions as the only known extracellular inhibitor of EGFR, with clearly identified roles in multiple stages of development. Argos is only expressed when the Drosophila EGFR (DER) is activated at high levels, and downregulates further DER signalling. Although there is ample genetic evidence that Argos inhibits DER activation, the biochemical mechanism has not been established. Here we show that Argos inhibits DER signalling without interacting directly with the receptor, but instead by sequestering the DER-activating ligand Spitz. Argos binds tightly to the EGF motif of Spitz and forms a 1:1 (Spitz:Argos) complex that does not bind DER in vitro or at the cell surface. Our results provide an insight into the mechanism of Argos function, and suggest new strategies for EGFR inhibitor design.

[1]  Naama Barkai,et al.  Modeling Pattern Formation: Counting to Two in the Drosophila Egg , 2002, Current Biology.

[2]  Markus Affolter,et al.  Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.

[3]  K. L. Kramer,et al.  Heparan sulfate core proteins in cell-cell signaling. , 2003, Annual review of genetics.

[4]  D. Lauffenburger,et al.  Computational modeling of the EGF-receptor system: a paradigm for systems biology. , 2003, Trends in cell biology.

[5]  C. Gabay,et al.  Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.

[6]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[7]  M. Freeman,et al.  An Autoregulatory Cascade of EGF Receptor Signaling Patterns the Drosophila Egg , 1998, Cell.

[8]  Antony W Burgess,et al.  Epidermal growth factor receptor: mechanisms of activation and signalling. , 2003, Experimental cell research.

[9]  M. Freeman,et al.  Evidence that Argos is an antagonistic ligand of the EGF receptor , 2000, Oncogene.

[10]  B. Shilo,et al.  Signaling by the Drosophila epidermal growth factor receptor pathway during development. , 2003, Experimental cell research.

[11]  I. Pastan,et al.  Direct visualization of binding, aggregation, and internalization of insulin and epidermal growth factor on living fibroblastic cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Hyun-soo Cho,et al.  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. , 2003, Molecular cell.

[13]  N. Normanno,et al.  Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.

[14]  C. Duan.  Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. , 2002, The Journal of endocrinology.

[15]  B. Shilo,et al.  Secreted Spitz triggers the DER signaling pathway and is a limiting component in embryonic ventral ectoderm determination. , 1995, Genes & development.

[16]  Peter Klein,et al.  The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Lemmon,et al.  Extracellular domains drive homo‐ but not hetero‐dimerization of erbB receptors , 2000, The EMBO journal.

[18]  M Locati,et al.  Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.

[19]  M. Freeman,et al.  In Vivo Analysis of Argos Structure-Function , 1998, The Journal of Biological Chemistry.

[20]  J. Turnbull,et al.  Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. , 2004, Glycobiology.

[21]  M. Freeman,et al.  Argos transcription is induced by the Drosophila EGF receptor pathway to form an inhibitory feedback loop. , 1996, Development.

[22]  A. Economides,et al.  Heparan Sulfate Proteoglycans Retain Noggin at the Cell Surface , 2002, The Journal of Biological Chemistry.

[23]  Douglas A Lauffenburger,et al.  Modeling and computational analysis of EGF receptor-mediated cell communication in Drosophila oogenesis. , 2002, Development.

[24]  M. Freeman,et al.  Inhibition of Drosophila EGF receptor activation by the secreted protein Argos , 1995, Nature.

[25]  P J Verveer,et al.  Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. , 2000, Science.

[26]  H. Okano,et al.  The Interaction between the DrosophilaSecreted Protein Argos and the Epidermal Growth Factor Receptor Inhibits Dimerization of the Receptor and Binding of Secreted Spitz to the Receptor , 2000, Molecular and Cellular Biology.

[27]  G. Rubin,et al.  The argos gene encodes a diffusible factor that regulates cell fate decisions in the drosophila eye , 1992, Cell.